Barts Cancer Institute (Queen Mary University of London)
@qmbci.bsky.social
Barts Cancer Institute is a leading UK cancer research institute, part of Queen Mary University of London and a partner in the Cancer Research UK City of London Centre. 🧪🧬🔬 https://www.bci.qmul.ac.uk/
Could vitamin B5 help treat severe anaemia in people with rare blood cancers? 🩸 That's the question @qmul.bsky.social researchers are exploring using funding from us. The answer could provide a new treatment... Read this & other impact stories in our new Impact Report: https://bit.ly/3V7JdjG
Are you a #clinician in training? Do you want to do a #PhD in #cancerresearch? 🧪🔬🦠🧫 Recruitment for the September 2026 start is open now!👨🏾🔬👩🔬 Check out our website for more information and potential supervisors. www.colcc.ac.uk/clinical-res...
Clinical Research Training Fellowships (CRTF) new
Aimed at clinicians who wish to undertake PhD research training. Applications for the 2027 Clinical Research Training Fellowships is open info package Application system will open soon Clinical ...
colcc.ac.uk
🧬 Can the way cancer cells copy their DNA reveal which treatments will work? BCI researchers have uncovered a mechanism that could help explain why some cancer cells are particularly sensitive to ATR-inhibitor drugs. 🧪 #MedSky #CanSky #OncoSky @qmul.bsky.social
DNA-copying overload may reveal which cancer cells respond to ATR-inhibitor drugs - Barts Cancer Institute, Queen Mary University of London
Researchers have uncovered a mechanism that makes some cancer cells especially vulnerable to experimental drugs known as ATR inhibitors. The findings could support the development of tests to identify...
bci.qmul.ac.uk
New BCI research involving 57,000+ British Bangladeshi and Pakistani people found that several cancers were diagnosed at younger ages and identified rare cancer-associated genetic changes absent from major genomic databases. 🧪 #Medsky #Oncosky @qmul.bsky.social @bartscharity.bsky.social
Study reveals gaps in cancer risk assessment and genetic tools for British Bangladeshi and Pakistani communities - Barts Cancer Institute
Scientists have carried out one of the largest and most comprehensive studies to date of the genetic and clinical factors associated with cancer in British Bangladeshi and Pakistani people. The findin...
bci.qmul.ac.uk
Scientists at BCI have uncovered an important way that cells keep their genes under control. The discovery could help explain one of the earliest molecular changes that occurs during the development of lung cancer. 🧪 #MedSky #OncoSky @qmul.bsky.social
Protein lost in lung cancer reveals hidden layer of gene control - Barts Cancer Institute
Scientists at Barts Cancer Institute, Queen Mary University of London, have uncovered an important way that cells keep their genes under control. The discovery could help explain one of the earliest m...
bci.qmul.ac.uk
How can artificial intelligence help us spot the faint signs of cancer in a blood sample? Prof Nitzan Rosenfeld and team at BCI @qmul.bsky.social have developed a new AI tool that combines multiple clues carried by DNA fragments in the blood. 🧪 #medsky #oncosky @cancerresearchuk.org
AI combines multiple DNA clues to improve cancer detection from blood - Barts Cancer Institute
Researchers have developed an artificial intelligence method that can detect signs of cancer by combining several different clues found in DNA fragments circulating in the blood. The method, developed...
bci.qmul.ac.uk
The major drivers of liver cancer are largely preventable – yet public awareness of the disease remains low.
Liver cancer deaths are rapidly increasing – tackling preventable causes would save lives
The major drivers of liver cancer are largely preventable – yet public awareness of the disease remains low.
tcnv.link
Paulo Ribeiro, @aashikasekar.bsky.social et al @qmbci.bsky.social find that protein phosphatase PP2A activates the Hippo pathway in Drosophila, in addition to its role as a Hippo negative regulator as part of the STRIPAK complex link.springer.com/article/10.1...
PP2A phosphatase regulates Hippo signalling in dual manner - The EMBO Journal
Hippo signalling is an evolutionarily conserved pathway that regulates tissue growth. The FERM domain protein Expanded (Ex) integrates polarity cues to activate the Hippo pathway. Previous work has sh...
link.springer.com
Congratulations to Dr Gabriella Ficz and team (@ficzlab.bsky.social), who have been awarded £880,000 as part of a £5.7m collaboration 'epiPRIME' exploring a new approach to antiviral protection, funded by @aria-research.bsky.social today. @qmul.bsky.social @qmulfmd.bsky.social 🧪
Scientists awarded £5.7m to harness epigenetics in next-generation anti-viral therapies
Researchers at Barts Cancer Institute, Queen Mary University of London, have been awarded funding as part of a £5.7m national collaborative initiative exploring how epigenetics – the processes that co...
bci.qmul.ac.uk
Triple-negative breast cancer can be difficult to treat, partly because immune cells may struggle to access the tumour. Researchers in Dr Oliver Pearce’s lab have found that modifying the tumour’s “sugar-coated” scaffold could help make it easier to treat. #medsky #oncosky 🧪 @qmul.bsky.social
‘Sugar-coated’ tumour matrix may offer way to make triple-negative breast cancer easier to treat
Researchers at Barts Cancer Institute, Queen Mary University of London, have discovered a way in which the environment surrounding triple-negative breast cancer cells helps suppress our immune system,...
bci.qmul.ac.uk
Fantastic experience chairing and organising inaugural London Genome Instability Conference (LOGIC) at @qmbci.bsky.social with @audreylumeau.bsky.social & @mollyguscott.bsky.social , brilliant talks on DNA damage, cancer initiation and genome evolution. Looking forward to doing it again next year!
Excited to share our new paper just out in @cp-cellreports.bsky.social We identified a signalling axis by which monocytes can directly impair NK cell cytotixocity in #metastasis. Led by @ChristosErmogenous and supported by a great team effort @qmbci.bsky.social www.cell.com/cell-reports...
MIF mediates monocyte-dependent inhibition of natural killer cell cytotoxicity in triple-negative breast cancer
Ermogenous et al. show that monocyte-derived MIF suppresses NK cell activation and cytotoxicity through CXCR4, weakening immune control of metastatic seeding in breast cancer. MIF inhibition reverses ...
cell.com
Congratulations to Prof. Louise Jones, who has been elected Fellow of @acmedsci.bsky.social. 👏 Learn more about Prof. Jones' work to understand breast cancer, advance the use of AI in cancer care and realise the potential of personalised medicine ⤵️ @qmul.bsky.social 🧪 #oncosky #medsky
Professor Louise Jones elected Fellow of the Academy of Medical Sciences - Barts Cancer Institute - Queen Mary University of London
Professor Louise Jones at Barts Cancer Institute, Queen Mary University of London, has been elected to the Academy of Medical Sciences. She joins 60 exceptional biomedical and health scientists electe...
bci.qmul.ac.uk
Most of us develop gene mutations linked to blood cancer as we age, but only a small proportion go on to develop the disease. New research from @benjaminwerner.bsky.social and team at BCI explores why, showing how mutated cells compete and evolve over time. 🧪 #medsky #oncosky @qmul.bsky.social
Study offers clues to blood cancer risk, revealing how gene mutations compete over time
Researchers have developed a new way to understand how genetic changes linked to blood cancer evolve in our cells, offering new insight into predicting blood cancer risk.
bci.qmul.ac.uk
Congratulations to Dr @kevinrouault.bsky.social, who has been awarded £1m from @cancerresearchuk.org to launch a clinical trial aiming to improve quality of life for people with myelodysplastic syndromes, a form of blood cancer with limited treatment options. 🧪 #medsky #oncosky @qmul.bsky.social
New £1m clinical trial launches to improve quality of life for people with blood cancer
Researchers have been awarded £1m to launch a new clinical trial for people with myelodysplastic syndromes, a form of blood cancer with limited treatment options.
bci.qmul.ac.uk
🔬 Watch how cancer and immune cells interact in a living system. Scientists at BCI have developed mini lab-grown ovarian tumours that recreate the complex neighbourhood of cells in patients. Published today in @natcomms.nature.com. Read more: bit.ly/4bMCrVg 🧪 #medsky #oncosky @qmul.bsky.social
onlinelibrary.wiley.com/doi/10.1111/... Thrilled to share our work in BJH highlighting the therapeutic potential of targeting the WNT pathway to block the crosstalk among stromal and leukemic ALL cells to prevent chemoresistance. Collab. w/ Bela Wrench @foteinikal.bsky.social @qmbci.bsky.social
Chemotherapy‐driven expression of WNT ligands in bone marrow stromal cells contributes to chemoresistance in acute lymphoblastic leukaemia
Chemotherapy-induced WNT ligand secretion by bone marrow (BM) stroma drives acute lymphoblastic leukaemia (ALL) chemoresistance. WNT pathway inhibition disrupts this cross-talk and restores therapeut....
onlinelibrary.wiley.com
Congratulations to Professor Michelle Lockley and Dr Oliver Pearce, who have been awarded prestigious @cancerresearchuk.org Programme Foundation Awards, worth nearly £1.5m each. Read more about their work seeking novel cancer therapy targets in our Q&A. 🧪 #medsky #oncosky @qmul.bsky.social
Barts Cancer Institute teams awarded nearly £3m from Cancer Research UK to seek novel cancer therapy targets - Barts Cancer Institute - Queen Mary University of London
Professor Michelle Lockley and Dr Oliver Pearce have both been awarded prestigious Programme Foundation Awards from Cancer Research UK, worth nearly £1.5 million each, to support the work of their res...
bci.qmul.ac.uk
Today, on #WorldCancerDay, we’re taking you behind the scenes at Queen Mary's Barts Cancer Institute and introducing you to the people who are making progress possible. Follow us to stay up to date with new developments. 🧪 #UnitedByUnique #MedSky #OncoSky @qmul.bsky.social @cancerresearchuk.org
Driving discoveries for tomorrow's cancer care at Barts Cancer Institute
YouTube video by BCIQMUL
youtu.be
People with a rare eye cancer (uveal melanoma) that has spread to the liver may survive for longer when doctors take a more active approach to monitoring and treatment, according to results from Professor Hemant Kocher and team. @qmul.bsky.social #medsky #oncosky 🧪
New approach offers hope for people with rare eye cancer - Barts Cancer Institute - Queen Mary University of London
A more active approach to monitoring and treating people with a rare eye cancer (known as uveal melanoma) that has spread to the liver could help some patients to live longer, according to researchers...
bci.qmul.ac.uk
Transgender Awareness Week & we complete our episode with the wonderful Dr Alison Berner⭐️ 🎙️ UCATS & OUTpatients work supporting the transgender community 🎙️Don’t let fear of Saying the wrong thing stop you DOING the right things⭐️ @drallycat.bsky.social @oncodaily.bsky.social @qmbci.bsky.social
📰 15 years of research by Prof. Tatjana Crnogorac-Jurcevic at BCI have led to the launch of Procyon Diagnostics, a new Queen Mary Innovation #spinout company developing a simple test for early #PancreaticCancer detection. @qmul.bsky.social | @qminnovation.bsky.social 🧪 #medsky #oncosky Read more ⤵️
New spinout launches to advance early pancreatic cancer detection
Queen Mary University of London has launched a new company, Procyon Diagnostics, to provide pioneering early cancer detection tests. The company’s first test, PancRISK, offers new hope for detecting p...
bci.qmul.ac.uk
Interested in carrying out research in cancer Radiotherapy and Radiobiology? Applications are open now for our PhD programme for 2026 intake! @kingscollegelondon.bsky.social @qmbci.bsky.social @crick.ac.uk @ucl.ac.uk crukradnet.colcc.ac.uk/phd-students...
PhD Studentships Projects - CRUK RadNet
Applications now open for PhD Studentships for September 2026 The CRUK City of London Radiation Research Centre PhD Programme This is a unique multidisciplinary and collaborative training opportuni...
crukradnet.colcc.ac.uk
The PhD will supervised by both myself and @mirazrahman.bsky.social at @qmbci.bsky.social and @kingscollegelondon.bsky.social, and is an outstanding opportunity to gain expertise in structural biology, medicinal chemistry, and cancer biology, at the cutting edge of translational oncology.
Proud to partner @cancerresearchuk.org and Windsor Fellowship to offer Black Leaders in Cancer #PhD scholarships. Check our projects and apply by Weds 5 Nov: https://www.colcc.ac.uk/black-leaders-phd-programme/ @qmbci.bsky.social @kingslsm.bsky.social @uclmedsci.bsky.social @crick.ac.uk #CRUKFunded
Check out some of the #PhD projects we have on offer, starting Sept 2026. Find out more and apply by noon, Weds 5 Nov: https://www.colcc.ac.uk/phd-studentships/ @qmbci.bsky.social @kingslsm.bsky.social @uclmedsci.bsky.social @crick.ac.uk #CRUKFunded
Our first Centre for Cancer Evolution PI retreat! A wonderful day at Goodenough House discussing science, strategy and forging new collaborations @qmbci.bsky.social
Come and join us at the Barts Cancer Institute @qmbci.bsky.social ! Our medical school, part of Queen Mary University of London @qmulfmd.bsky.social is hiring 10 professors!! www.veredus.co.uk/job/job-747a/. Contact me for a chat if interested.
Professors x 10, Faculty of Medicine & Dentistry | Veredus
QUEEN MARY UNIVERSITY OF LONDON Professors x 10, Faculty of Medicine and Dentistry London Competitive Remuneration Package Queen Mary University of London seeks up to 10 world-leading translational re...
veredus.co.uk
Could imaging, genetic and biomarker tests improve early #ProstateCancer detection? A team led by Prof Prabhakar Rajan @qmbci.bsky.social explore different detection strategies in their latest publication in @bjuijournal.bsky.social. Grab a ☕ and read: doi.org/10.1002/bco2...
📰 A new AI tool could help doctors identify which skin cancers are most likely to spread. We spoke to Professor Alex Wang and Dr Emilia Peleva to find out more about their new study and next steps ⬇ @qmul.bsky.social | @cruk-cityoflondon.bsky.social 🧪 #medsky #oncosky #ArtificialIntelligence
New AI model sheds light on high-risk skin cancer: Q&A with the authors - Barts Cancer Institute - Queen Mary University of London
Researchers at Barts Cancer Institute (BCI), Queen Mary University of London, have developed an artificial intelligence (AI) tool that could help doctors identify which skin cancers are most likely to...
bci.qmul.ac.uk